Highbridge Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Highbridge Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-30,734	Closed	-$1.91M	–	377
2018 Q3	$1.91M	Buy	+30,734	New	+$1.82M	0.05%	338
2018 Q2	–	Sell	-81,081	Closed	-$4.38M	–	947
2018 Q1	$5.13M	Sell	81,081 -173,060	-68%	-$11.1M	0.08%	286
2017 Q4	$15.6M	Buy	254,141 +135,244	+114%	+$8.46M	0.28%	84
2017 Q3	$7.58M	Sell	118,897 -107,286	-47%	-$6.26M	0.11%	209
2017 Q2	$12.6M	Sell	226,183 -190,429	-46%	-$10.4M	0.19%	131
2017 Q1	$22.7M	Buy	416,612 +410,543	+6,765%	+$22.5M	0.33%	77
2016 Q4	$355K	Sell	6,069 -405,841	-99%	-$22.2M	0.01%	899
2016 Q3	$22.2M	Buy	+411,910	New	+$26.5M	0.35%	62
2015 Q4	–	Sell	-23,375	Closed	-$1.38M	–	1514
2015 Q3	$1.38M	Buy	+23,375	New	+$1.48M	0.02%	665
2015 Q2	–	Sell	-243,117	Closed	-$15.7M	–	1401
2015 Q1	$15.7M	Buy	243,117 +229,619	+1,701%	+$14.4M	0.22%	132
2014 Q4	$797K	Buy	+13,498	New	+$761K	0.01%	705
2014 Q3	–	Sell	-242,312	Closed	-$11.8M	–	1211
2014 Q2	$11.8M	Buy	+242,312	New	+$11.9M	0.14%	168
2013 Q3	–	Sell	-47,586	Closed	-$2.09M	–	1275
2013 Q2	$2.13M	Buy	+47,586	New	+$2.07M	0.02%	477

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Highbridge Capital Management's BMY Position: Q4 2018 in Review

Highbridge Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2018, closing a stake of 30,734 shares — an estimated $1.91M sold.

Highbridge Capital Management first reported a position in BMY in Q2 2013 and held it in 13 quarters. The position peaked at $22.7M in Q1 2017. 1,766 funds tracked by Wall St. Rank hold BMY as of Q4 2018.

Highbridge Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2018 after selling out during the quarter.
Highbridge Capital Management sold 30,734 Bristol-Myers Squibb shares in Q4 2018, an estimated $1.91M.
Highbridge Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 13 quarters.
Highbridge Capital Management's Bristol-Myers Squibb position peaked at $22.7M in Q1 2017.
1,766 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.